Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients

NCT00179062 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00179062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients
Lead sponsor
Vanderbilt University
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2000
Completion date
June 30, 2007
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depressive disorder, major, schizoaffective disorder, schizophrenia